MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Operating Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹1,902 Cr | ₹1,991 Cr | ₹1,649 Cr | ₹1,445 Cr | ₹925 Cr |
What is the latest Operating Profit of MANKIND PHARMA ?
Year | Operating Profit |
---|---|
Mar2023 | ₹1,902 Cr |
Mar2022 | ₹1,991 Cr |
Mar2021 | ₹1,649 Cr |
Mar2020 | ₹1,445 Cr |
Mar2019 | ₹925 Cr |
How is Operating Profit of MANKIND PHARMA Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹1,902 Cr | -4.45 | |
Mar2022 | ₹1,991 Cr | 20.70 | |
Mar2021 | ₹1,649 Cr | 14.15 | |
Mar2020 | ₹1,445 Cr | 56.18 | |
Mar2019 | ₹925 Cr | - |
Compare Operating Profit of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹87,757.4 Cr | 1.1% | -5.5% | 62.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹366,354.0 Cr | 2.3% | -0.8% | 60.8% | Stock Analytics | |
CIPLA | ₹113,516.0 Cr | 3.5% | 0.7% | 43.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,352.0 Cr | 2.7% | 3% | 17.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,367.0 Cr | 3.1% | 3.8% | 91.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,961.5 Cr | -0.1% | -3.5% | 29.5% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 1.1% |
-5.5% |
62.9% |
SENSEX | -0.7% |
-2.7% |
17.8% |
You may also like the below Video Courses